Adaptive Biotechnologies

Adaptive Highlights MRD Testing in New Myeloma Cure Definition

SEATTLE — September 25, 2026 Adaptive Biotechnologies highlighted a new consensus definition of cure for multiple myeloma presented at...

By cGxPwire Editor
September 28, 2026

MedTech

Adaptive Highlights Updated NCCN MRD Guidance in Multiple Myeloma

SEATTLE, Wash. — September 17, 2026 Adaptive Biotechnologies highlighted updates to the National Comprehensive Cancer Network (NCCN) Guidelines for...

By cGxPwire Editor
September 21, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Adaptive Biotechnologies

Adaptive Highlights MRD Testing in New Myeloma Cure Definition

Adaptive Highlights Updated NCCN MRD Guidance in Multiple Myeloma